CLS Holdings USA Inc (CLSH)
0.054
0.00 (0.00%)
USD |
OTCM |
Apr 26, 15:59
CLS Holdings USA Profit Margin (Quarterly): -88.69% for Feb. 29, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -88.69% |
| November 30, 2023 | -25.06% |
| August 31, 2023 | -9.07% |
| May 31, 2023 | -63.40% |
| February 28, 2023 | -16.54% |
| November 30, 2022 | -135.3% |
| August 31, 2022 | -19.00% |
| May 31, 2022 | -23.26% |
| February 28, 2022 | -17.76% |
| November 30, 2021 | -6.38% |
| August 31, 2021 | 7.77% |
| May 31, 2021 | -168.1% |
| Date | Value |
|---|---|
| February 28, 2021 | -81.71% |
| November 30, 2020 | -17.31% |
| August 31, 2020 | -30.28% |
| May 31, 2020 | -962.8% |
| February 29, 2020 | -38.83% |
| November 30, 2019 | -41.94% |
| August 31, 2019 | -48.15% |
| May 31, 2019 | -117.1% |
| February 28, 2019 | -203.6% |
| November 30, 2018 | -136.5% |
| August 31, 2018 | -1.41K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-962.8%
Minimum
May 2020
7.77%
Maximum
Aug 2021
-95.14%
Average
-34.56%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -88.65% |
| Gross Profit Margin (Quarterly) | 43.17% |
| Operating Margin (Quarterly) | -8.90% |
| Return on Net Operating Assets | -101.3% |